|
1
|
Arndt CA and Crist WM: Common
musculoskeletal tumors of childhood and adolescence. N Engl J Med.
341:342–352. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Endo-Munoz L, Cumming A, Sommerville S,
Dickinson I and Saunders NA: Osteosarcoma is characterised by
reduced expression of markers of osteoclastogenesis and antigen
presentation compared with normal bone. Br J Cancer. 103:73–81.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tabori U and Dome JS: Telomere biology of
pediatric cancer. Cancer Invest. 25:197–208. 2007. View Article : Google Scholar
|
|
4
|
Brachner A, Sasgary S, Pirker C, et al:
Telomerase- and alternative telomere lengthening-independent
telomere stabilization in a metastasis-derived human non-small cell
lung cancer cell line: effect of ectopic hTERT. Cancer Res.
66:3584–3592. 2006. View Article : Google Scholar
|
|
5
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith CC, Aylott MC, Fisher KJ, Lynch AM
and Gooderham NJ: DNA damage responses after exposure to DNA-based
products. J Gene Med. 8:175–85. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smogorzewska A, Karlseder J,
Holtgreve-Grez H, Jauch A and de Lange T: DNA ligase IV-dependent
NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol.
12:1635–1644. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
D’Adda di Fagagna F, Reaper PM,
Clay-Farrace L, et al: A DNA damage checkpoint response in
telomere-initiated senescence. Nature. 426:194–198. 2003.PubMed/NCBI
|
|
9
|
Bakkenist CJ, Drissi R, Wu J, Kastan MB
and Dome JS: Disappearance of the telomere dysfunction-induced
stress response in fully senescent cells. Cancer Res. 64:3748–3752.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shay JW and Wright WE: Hayflick, his
limit, and cellular ageing. Nat Rev Mol Cell Biol. 1:72–76. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Makarov VL, Hirose Y and Langmore JP: Long
G tails at both ends of human chromosomes suggest a C strand
degradation mechanism for telomere shortening. Cell. 88:657–666.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Palm W and de Lange T: How shelterin
protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Artandi SE and DePinho RA: Telomeres and
telomerase in cancer. Carcinogenesis. 31:9–18. 2010. View Article : Google Scholar
|
|
14
|
Weinrich SL, Pruzan R, Ma L, et al:
Reconstitution of human telomerase with the template RNA component
hTR and the catalytic protein subunit hTRT. Nat Genet. 17:498–502.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henson JD, Neumann AA, Yeager TR and
Reddel RR: Alternative lengthening of telomeres in mammalian cells.
Oncogene. 21:598–610. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu ZX, Zou WX, Lin P and Chang KS: A role
for PML3 in centrosome duplication and genome stability. Mol Cell.
17:721–732. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakayama J, Tahara H, Tahara E, et al:
Telomerase activation by hTRT in human normal fibroblasts and
hepatocellular carcinomas. Nat Genet. 18:65–68. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blasco MA, Funk W, Villeponteau B and
Greider CW: Functional characterization and developmental
regulation of mouse telomerase RNA. Science. 269:1267–1270. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Avilion AA, Piatyszek MA, Gupta J, Shay
JW, Bacchetti S and Greider CW: Human telomerase RNA and telomerase
activity in immortal cell lines and tumor tissues. Cancer Res.
56:645–650. 1996.PubMed/NCBI
|
|
20
|
Beattie TL, Zhou W, Robinson MO and
Harrington L: Polymerization defects within human telomerase are
distinct from telomerase RNA and TEP1 binding. Mol Biol Cell.
11:3329–3340. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kickhoefer VA, Stephen AG, Harrington L,
Robinson MO and Rome LH: Vaults and telomerase share a common
subunit, TEP1. J Biol Chem. 274:32712–32717. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kickhoefer VA, Liu Y, Kong LB, et al: The
telomerase/vault-associated protein TEP1 is required for vault RNA
stability and its association with the vault particle. J Cell Biol.
152:157–164. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Snow BE, Hande MP, et al:
Telomerase-associated protein TEP1 is not essential for telomerase
activity or telomere length maintenance in vivo. Mol Cell Biol.
20:8178–8184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ulaner GA, Huang HY, Otero J, et al:
Absence of a telomere maintenance mechanism as a favorable
prognostic factor in patients with osteosarcoma. Cancer Res.
63:1759–1763. 2003.PubMed/NCBI
|
|
25
|
Terasaki T, Kyo S and Takakura M: Analysis
of telomerase activity and telomere length in bone and soft tissue
tumors. Oncol Rep. 11:1307–1311. 2004.PubMed/NCBI
|
|
26
|
Fujiwara-Akita H, Maesawa C, Honda T,
Kobayashi S and Masuda T: Expression of human telomerase reverse
transcriptase splice variants is well correlated with low
telomerase activity in osteosarcoma cell lines. Int J Oncol.
26:1009–1016. 2005.PubMed/NCBI
|
|
27
|
Sotillo-Piñeiro E, Sierrasesúmaga L and
Patiñno-García A: Telomerase activity and telomere length in
primary and metastatic tumors from pediatric bone cancer patients.
Pediatr Res. 55:231–235. 2004.PubMed/NCBI
|
|
28
|
Yu ST, Chen L, Wang HJ, Tang XD, Fang DC
and Yang SM: hTERT promotes the invasion of telomerase-negative
tumor cells in vitro. Int J Oncol. 35:329–336.
2009.PubMed/NCBI
|
|
29
|
Jegou T, Chung I, Heuvelman G, et al:
Dynamics of telomeres and promyelocytic leukemia nuclear bodies in
a telomerase-negative human cell line. Mol Biol Cell. 20:2070–2082.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanders RP, Drissi R, Billups CA, Daw NC,
Valentine MB and Dome JS: Telomerase expression predicts
unfavorable outcome in osteosarcoma. J Clin Oncol. 22:3790–3797.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herbert BS, Gellert GC, Hochreiter A, et
al: Lipid modification of GRN163, an N3′→P5′ thio-phosphoramidate
oligonucleotide, enhances the potency of telomerase inhibition.
Oncogene. 24:5262–5268. 2005.PubMed/NCBI
|
|
32
|
Pascolo E, Wenz C, Lingner J, et al:
Mechanism of human telomerase inhibition by BIBR1532, a synthetic,
non-nucleosidic drug candidate. J Biol Chem. 277:15566–15572. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perrem K, Colgin LM, Neumann AA, Yeager TR
and Reddel RR: Coexistence of alternative lengthening of telomeres
and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol.
21:3862–3875. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Costa A, Daidone MG, Daprai L, et al:
Telomere maintenance mechanisms in liposarcomas: association with
histologic subtypes and disease progression. Cancer Res.
66:8918–8924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bhattacharyya S, Sandy A and Groden J:
Unwinding protein complexes in ALTernative telomere maintenance. J
Cell Biochem. 109:7–15. 2010.PubMed/NCBI
|
|
36
|
Mankouri HW and Hickson ID: The RecQ
helicase-topoisomerase III-Rmi1 complex: a DNA structure-specific
‘dissolvasome’? Trends Biochem Sci. 32:538–546. 2007.PubMed/NCBI
|
|
37
|
Raynard S, Zhao W, Bussen W, et al:
Functional role of BLAP75 in BLM-topoisomerase IIIalpha-dependent
holliday junction processing. J Biol Chem. 283:15701–15708. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang WQ, Zhong ZH, Henson JD, Neumann AA,
Chang AC and Reddel RR: Suppression of alternative lengthening of
telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1
complex. Mol Cell Biol. 25:2708–2721. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sugawara N, Wang X and Haber JE: In vivo
roles of Rad52, Rad54, and Rad55 proteins in Rad51-mediated
recombination. Mol Cell. 2:209–219. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Miyazaki T, Bressan DA, Shinohara M, Haber
JE and Shinohara A: In vivo assembly and disassembly of Rad51 and
Rad52 complexes during double-strand break repair. EMBO J.
3:939–949. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saharia A and Stewart SA: FEN1 contributes
to telomere stability in ALT-positive tumor cells. Oncogene.
28:1162–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zeng S, Xiang T, Pandita TK, et al:
Telomere recombination requires the MUS81 endonuclease. Nat Cell
Biol. 11:616–623. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fan Q, Zhang F, Barrett B, Ren K and
Andreassen PR: A role for monoubiquitinated FANCD2 at telomeres in
ALT cells. Nucleic Acids Res. 37:1740–1754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu G, Jiang X, Lee WH and Chen PL:
Assembly of functional ALT-associated promyelocytic leukemia bodies
requires Nijmegen Breakage Syndrome 1. Cancer Res. 63:2589–2595.
2003.PubMed/NCBI
|
|
45
|
Henson JD, Cao Y, Huschtscha LI, et al:
DNA C-circles are specific and quantifiable markers of
alternative-lengthening-of-telomeres activity. Nat Biotechnol.
27:1181–1185. 2009. View
Article : Google Scholar : PubMed/NCBI
|
